Skip to Main Content

Paper Details

Variants on the UBE2L3/YDJC Autoimmune Disease Risk Haplotype Increase UBE2L3 Expression by Modulating CCCTC-Binding Factor and YY1 Binding.
Arthritis and Rheumatology
3
2022
rs140491,, -, -YDJC, -YDJC autoimmune risk haplotype, CTCF, E2 ubiquitin-conjugating enzyme, EBV, NF-B, UBE2L3, UBE2L3 and YDJC promoters, UBE2L3 gene, UBE2L3 promoter, UbcH7, YDJC, YDJC promoter, YDJC promoters, YDJC risk haplotype, YY1, allele, autoimmune disease, autoimmune diseases, chromatin, chromatin accessible regions, immune cells, luciferase reporter, patient, patient-derived EBV-transformed B cells, promoters, risk alleles, risk variants, rs11089620, rs140490, rs140491, rs3747093, ubiquitin-conjugating enzyme E2 L3, ubiquitin-conjugating enzyme E2 L3 (UBE2L3) gene
Author NameAffiliation
Patrick M GaffneyOklahoma Medical Research Foundation and University of Oklahoma Health Sciences Center
  • 1 - 1

Datasets

Release 1.2